Inverness to launch early HIV test in developing world
This article was originally published in Clinica
Inverness Medical Innovations plans to launch its Determine HIV-1/2 Ag/AB Combo test in the developing world in the third quarter. The diagnostic can detect HIV infections earlier than current HIV antibody-only tests, the Waltham, Massachusetts firm said. It detects HIV p24 antigen, which is present during the first few weeks of HIV infection before HIV antibodies are produced, as well as antibodies for HIV-1 and -2. The point-of-care test can provide results in 20 minutes. Inverness unveiled it at the International AIDS Conference (AIDS 2008) in Mexico City last week, along with its Clearview TB ELISA, to detect TB in patients co-infected with HIV.